{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:55:15Z","timestamp":1787738115108,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11899-015-0291-0","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T05:09:23Z","timestamp":1444280963000},"page":"448-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project"],"prefix":"10.1007","volume":"10","author":[{"given":"Monica","family":"Bellei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadi","family":"Nabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela Anna","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Foss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"issue":"12","key":"291_CR1","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835\u201349.","journal-title":"J Clin Oncol"},{"key":"291_CR2","volume-title":"Tumours of haematopoietic and lymphoid tissues\u2014pathology and genetics, World Health Organization of Tumours","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NLJWV. Tumours of haematopoietic and lymphoid tissues\u2014pathology and genetics, World Health Organization of Tumours. Lyon: IARC Press; 2001."},{"issue":"1","key":"291_CR3","first-page":"181","volume":"128","author":"LJ Picker","year":"1987","unstructured":"Picker LJ, Weiss LM, Medeiros LJ, Wood GS, Warnke RA. Immunophenotypic criteria for the diagnosis of non-Hodgkin\u2019s lymphoma. Am J Pathol. 1987;128(1):181\u2013201.","journal-title":"Am J Pathol"},{"issue":"11","key":"291_CR4","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","volume":"88","author":"CB Cooke","year":"1996","unstructured":"Cooke CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood. 1996;88(11):4265\u201374.","journal-title":"Blood"},{"issue":"1","key":"291_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJM200007063430107","volume":"343","author":"PJ Delves","year":"2000","unstructured":"Delves PJ, Roitt IM. The immune system. first of two parts. N Engl J Med. 2000;343(1):37\u201349.","journal-title":"N Engl J Med"},{"issue":"2","key":"291_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","volume":"343","author":"P Delves","year":"2000","unstructured":"Delves P, Roitt I. Advances in immunology: the immune system\u2014second of two parts. N Engl J Med. 2000;343(2):108\u201317.","journal-title":"N Engl J Med"},{"issue":"2","key":"291_CR7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.V96.2.685","volume":"96","author":"D Jones","year":"2000","unstructured":"Jones D, O\u2019Hara C, Kraus MD, et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood. 2000;96(2):685\u201390.","journal-title":"Blood"},{"issue":"12","key":"291_CR8","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","volume":"89","author":"A Melnyk","year":"1997","unstructured":"Melnyk A, Rodriguez A, Pugh WC, Cabannillas F. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma. Blood. 1997;89(12):4514\u201320.","journal-title":"Blood"},{"issue":"1","key":"291_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the non-Hodgkin\u2019s lymphoma classification project. Ann Oncol. 2002;13(1):140\u20139.","journal-title":"Ann Oncol"},{"issue":"8","key":"291_CR10","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"JO Armitage","year":"1998","unstructured":"Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. J Clin Oncol. 1998;16(8):2780\u201395.","journal-title":"J Clin Oncol"},{"issue":"2","key":"291_CR11","first-page":"171","volume":"82","author":"F Zaja","year":"1997","unstructured":"Zaja F, Russo D, Silvestri F, et al. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome. Haematologica. 1997;82(2):171\u20137.","journal-title":"Haematologica"},{"issue":"6","key":"291_CR12","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","volume":"15","author":"SM Ansell","year":"1997","unstructured":"Ansell SM, Habermann TM, Kurtin PJ, et al. Predictive capacity of the international prognostic factor index in patients with peripheral T-cell lymphoma. J Clin Oncol. 1997;15(6):2296\u2013301.","journal-title":"J Clin Oncol"},{"issue":"6","key":"291_CR13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","volume":"8","author":"S Ascani","year":"1997","unstructured":"Ascani S, Zinzani PL, Gherlinzoni F, et al. Peripheral T-cell lymphomas. clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification. Ann Oncol. 1997;8(6):583\u201392.","journal-title":"Ann Oncol"},{"issue":"8","key":"291_CR14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","volume":"9","author":"A L\u00f3pez-Guillermo","year":"1998","unstructured":"L\u00f3pez-Guillermo A, Cid J, Salar A, et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification. Ann Oncol. 1998;9(8):849\u201355.","journal-title":"Ann Oncol"},{"issue":"10","key":"291_CR15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"KJ Savage","year":"2004","unstructured":"Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol. 2004;15(10):1467\u201375.","journal-title":"Ann Oncol"},{"issue":"7","key":"291_CR16","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004;103(7):2474\u20139.","journal-title":"Blood"},{"issue":"1","key":"291_CR17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-05-1352","volume":"103","author":"T Tsuchiya","year":"2004","unstructured":"Tsuchiya T, Ohshima K, Karube K, et al. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood. 2004;103(1):236\u201341.","journal-title":"Blood"},{"key":"291_CR18","unstructured":"Foss F, Carson KR, Federico M, et al. Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE), a new international treatment registry. Ann Oncol. Abstract 242, 2011;22(4)."},{"issue":"25","key":"291_CR19","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"JM Vose","year":"2008","unstructured":"Vose JM, Neumann M, Harris ME. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project. J Clin Oncol. 2008;26(25):4124\u201330.","journal-title":"J Clin Oncol"},{"issue":"19","key":"291_CR20","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 2014;123(19):2915\u201323.","journal-title":"Blood"},{"issue":"24","key":"291_CR21","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1200\/JCO.2012.42.5611","volume":"31","author":"PP Piccaluga","year":"2013","unstructured":"Piccaluga PP, Fuligni F, De Leo A, et al. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol. 2013;31(24):3019\u201325. This study validated the ability of gene expression profiles (GEPs; index test) in identifying different PTCL subtypes.","journal-title":"J Clin Oncol"},{"issue":"2","key":"291_CR22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31(2):240\u20136.","journal-title":"J Clin Oncol"},{"issue":"8","key":"291_CR23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.23205","volume":"87","author":"Z Mitrovic","year":"2012","unstructured":"Mitrovic Z, Perry AM, Suzumiya J, et al. The prognostic significance of lymphopenia in peripheral T-cell and natural killer\/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project. Am J Hematol. 2012;87(8):790\u20134.","journal-title":"Am J Hematol"},{"issue":"1","key":"291_CR24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","volume":"118","author":"J Delabie","year":"2011","unstructured":"Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-cell Lymphoma Project. Blood. 2011;118(1):148\u201355.","journal-title":"Blood"},{"issue":"12","key":"291_CR25","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","volume":"117","author":"DD Weisenburger","year":"2011","unstructured":"Weisenburger DD, Savage KJ, Harris NL, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011;117(12):3402\u20138.","journal-title":"Blood"},{"issue":"2","key":"291_CR26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/leu.2010.255","volume":"25","author":"J Iqbal","year":"2011","unstructured":"Iqbal J, Weisenburger DD, Chowdhury A, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia. 2011;25(2):348\u201358.","journal-title":"Leukemia"},{"issue":"5","key":"291_CR27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115(5):1026\u201336.","journal-title":"Blood"},{"issue":"4","key":"291_CR28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdn696","volume":"20","author":"J Suzumiya","year":"2009","unstructured":"Suzumiya J, Ohshima K, Tamura K, et al. The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia\/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project. Ann Oncol. 2009;20(4):715\u201321.","journal-title":"Ann Oncol"},{"issue":"17","key":"291_CR29","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral TCell Lymphoma Project. Blood. 2009;113(17):3931\u20137.","journal-title":"Blood"},{"issue":"2","key":"291_CR30","first-page":"21","volume":"31","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Pesce E, et al. T-cell project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma. Rev Bras Hematol Hemoter. 2009;31(2):21\u20135.","journal-title":"Rev Bras Hematol Hemoter"},{"key":"291_CR31","unstructured":"Federico M, Bellei M., Pesce EA, et al. T-cell project: an international, prospective, observational study of patients with aggressive peripheral T-cell lymphoma. Analysis of first 524 patients. Ann Oncol. Abstract 241, 2011;22(4)."},{"key":"291_CR32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/hon.2227","volume":"33","author":"M Federico","year":"2015","unstructured":"Federico M, Bellei M, Pesce EA. T-cell project: an international, prospective, observational study of patients with aggressive peripheral NK\/T-cell lymphoma: lesson from the first 1308 patients. Hematol Oncol Abstract 070. 2015;33:100\u201380.","journal-title":"Hematol Oncol Abstract 070"},{"key":"291_CR33","first-page":"1614","volume":"120","author":"FM Foss","year":"2012","unstructured":"Foss FM, Carson KR, Pinter-Brown LC. Comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE): first detailed report of primary treatment. Blood, ASH Ann Meet Abstracts. 2012;120:1614.","journal-title":"Blood, ASH Ann Meet Abstracts"},{"key":"291_CR34","first-page":"4284","volume":"122","author":"KR Carson","year":"2013","unstructured":"Carson KR, Foss FM, Pinter-Brown LC, et al. Analysis of peripheral T-cell lymphoma (PTCL) subtype by race and geography using the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) dataset. Blood Abstract. 2013;122:4284.","journal-title":"Blood Abstract"},{"key":"291_CR35","doi-asserted-by":"crossref","unstructured":"Pinter-Brown LC, Foss FM, Carson KR, et al. Patient characteristics and initial treatment patterns in the United States for the most common subtypes of peripheral T-cell lymphoma (PTCL). Blood. ASH Ann Meet Abstract, 2014;124(21).","DOI":"10.1182\/blood.V124.21.4434.4434"},{"key":"291_CR36","first-page":"4263","volume":"120","author":"ED Hsi","year":"2012","unstructured":"Hsi ED, Gruver AM, Foss FM, et al. Biomarker quality assurance (QA) findings from the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) registry. Blood ASH Ann Meet Abstracts. 2012;120:4263.","journal-title":"Blood ASH Ann Meet Abstracts"},{"key":"291_CR37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hon.2228","volume":"33","author":"C Nabhan","year":"2015","unstructured":"Nabhan C, Foss FM, Horwitz SM. Characteristics and patterns of care of patients (pts) 70 years with T-cell non-Hodgkin lymphoma (TCL) in the United States (US). Hematol Oncol Abstract 232. 2015;33:181\u2013243.","journal-title":"Hematol Oncol Abstract 232"},{"issue":"1","key":"291_CR38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5581\/1516-8484.20120013","volume":"34","author":"M Bellei","year":"2012","unstructured":"Bellei M, Chiattone CS, Luminari S, et al. T-cell lymphomas in South America and Europe. Rev Bras Hematol Hemoter. 2012;34(1):42\u20137.","journal-title":"Rev Bras Hematol Hemoter"},{"key":"291_CR39","doi-asserted-by":"crossref","unstructured":"Federico M, Bellei M, Luminari S, et al. CD30 expression in peripheral T-cell lymphomas (PTCLs): a subset analysis from the international, prospective T-cell project. J Clin Oncol Abstract 8552, 2015;33(15).","DOI":"10.1200\/jco.2015.33.15_suppl.8552"},{"key":"291_CR40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hon.2228","volume":"33","author":"SM Horwitz","year":"2015","unstructured":"Horwitz SM, Bellei M, Marcheselli L. The role of transplant in the treatment of peripheral T-cell lymphomas (PTCLs): an analysis from the T-cell project database. Hematol Oncol Abstract 247. 2015;33:181\u2013243.","journal-title":"Hematol Oncol Abstract 247"},{"key":"291_CR41","first-page":"2650","volume":"120","author":"S Pileri","year":"2012","unstructured":"Pileri S, Bellei M, Vose JM. Evaluation of quality of biomarker data capture by peripheral sites in an international, cooperative study: analysis of 104 cases from the T-cell project. Blood ASH Ann Meet Abstracts. 2012;120:2650.","journal-title":"Blood ASH Ann Meet Abstracts"},{"key":"291_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hon.2228","volume":"33","author":"M Bellei","year":"2015","unstructured":"Bellei M, Marcheselli L, Pesce EA. Clinical characteristics and patterns of care of patients (pts) with peripheral T-cell lymphoma (PTCLs) according to age at time of diagnosis: a T-cell project snapshot. Hematol Oncol Abstract 231. 2015;33:181\u2013231.","journal-title":"Hematol Oncol Abstract 231"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-015-0291-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-015-0291-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-015-0291-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T11:03:18Z","timestamp":1599649398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-015-0291-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1007\/s11899-015-0291-0","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}